BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Simmonds MJ, Gough SC. Unravelling the genetic complexity of autoimmune thyroid disease: HLA, CTLA-4 and beyond. Clin Exp Immunol 2004;136:1-10. [PMID: 15030506 DOI: 10.1111/j.1365-2249.2004.02424.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Rekha PL, Ishaq M, Valluri V. A differential association of interferon-gamma high-producing allele T and low-producing allele A (+874 A/T) with Hashimoto's thyroiditis and Graves' disease. Scand J Immunol 2006;64:438-43. [PMID: 16970687 DOI: 10.1111/j.1365-3083.2006.01834.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
2 Ban Y, Tozaki T, Tobe T, Ban Y, Jacobson EM, Concepcion ES, Tomer Y. The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts. J Autoimmun. 2007;28:201-207. [PMID: 17418529 DOI: 10.1016/j.jaut.2007.02.016] [Cited by in Crossref: 101] [Cited by in F6Publishing: 92] [Article Influence: 7.2] [Reference Citation Analysis]
3 Kiseleva E, Mikhailopulo K, Novik G, Szwajcer Dey E, Zdorovenko E, Shashkov A, Knirel Y. Isolation and structural identification of glycopolymers of Bifidobacterium bifidum BIM B-733D as putative players in pathogenesis of autoimmune thyroid diseases. Beneficial Microbes 2013;4:375-91. [DOI: 10.3920/bm2013.0015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Brzoza Z, Grzeszczak W, Rogala B, Trautsolt W, Moczulski D. PTPN22 polymorphism presumably plays a role in the genetic background of chronic spontaneous autoreactive urticaria. Dermatology 2012;224:340-5. [PMID: 22722472 DOI: 10.1159/000339332] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
5 Kavvoura FK, Akamizu T, Awata T, Ban Y, Chistiakov DA, Frydecka I, Ghaderi A, Gough SC, Hiromatsu Y, Ploski R, Wang P, Ban Y, Bednarczuk T, Chistiakova EI, Chojm M, Heward JM, Hiratani H, Juo SH, Karabon L, Katayama S, Kurihara S, Liu R, Miyake I, Omrani GR, Pawlak E, Taniyama M, Tozaki T, Ioannidis JPA. Cytotoxic T-Lymphocyte Associated Antigen 4 Gene Polymorphisms and Autoimmune Thyroid Disease: A Meta-Analysis. The Journal of Clinical Endocrinology & Metabolism 2007;92:3162-70. [DOI: 10.1210/jc.2007-0147] [Cited by in Crossref: 123] [Cited by in F6Publishing: 113] [Article Influence: 8.8] [Reference Citation Analysis]
6 Jacobson EM, Tomer Y. The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future. J Autoimmun 2007;28:85-98. [PMID: 17369021 DOI: 10.1016/j.jaut.2007.02.006] [Cited by in Crossref: 130] [Cited by in F6Publishing: 115] [Article Influence: 9.3] [Reference Citation Analysis]
7 Hodge SE, Ban Y, Strug LJ, Greenberg DA, Davies TF, Concepcion ES, Villanueva R, Tomer Y. Possible interaction between HLA-DRbeta1 and thyroglobulin variants in Graves' disease. Thyroid 2006;16:351-5. [PMID: 16646680 DOI: 10.1089/thy.2006.16.351] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 3.4] [Reference Citation Analysis]
8 Koyanagi M, Nakabayashi K, Fujimoto T, Gu N, Baba I, Takashima Y, Doi K, Harada H, Kato N, Sasazuki T, Shirasawa S. ZFAT expression in B and T lymphocytes and identification of ZFAT-regulated genes. Genomics 2008;91:451-7. [DOI: 10.1016/j.ygeno.2008.01.009] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
9 Ajjan RA, Weetman AP. New insights into antibody-mediated hyperthyroidism. Expert Review of Endocrinology & Metabolism 2014;1:67-81. [DOI: 10.1586/17446651.1.1.67] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
10 Zeitlin AA, Simmonds MJ, Gough SCL. Genetic developments in autoimmune thyroid disease: an evolutionary process. Clin Endocrinol 2008;68:671-82. [DOI: 10.1111/j.1365-2265.2007.03075.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
11 Chen H, Cui B, Wang S, Zhao Z, Sun H, Gu X, Zhao Y, Li X, Ning G. The common variants of E-selectin gene in Graves' disease. Genes Immun 2008;9:182-6. [PMID: 18094708 DOI: 10.1038/sj.gene.6364452] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
12 Guarneri F, Benvenga S. Environmental factors and genetic background that interact to cause autoimmune thyroid disease: . Current Opinion in Endocrinology, Diabetes and Obesity 2007;14:398-409. [DOI: 10.1097/med.0b013e3282ef1c48] [Cited by in Crossref: 50] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
13 Shi Y, Shen M, Zheng X, Chen Y, Zhao R, Gu Y, Yang T. ICPis-Induced Autoimmune Polyendocrine Syndrome Type 2: A Review of the Literature and a Protocol for Optimal Management. The Journal of Clinical Endocrinology & Metabolism 2020;105:e4208-18. [DOI: 10.1210/clinem/dgaa553] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Pan B, Zhang Q, Zhou H, Ma ZF. Prevalence of Components of Metabolic Syndrome Among Adults with the Presence of Autoimmune Thyroid Condition in an Iodine-Sufficient Region. Biol Trace Elem Res 2021;199:2837-43. [PMID: 33006706 DOI: 10.1007/s12011-020-02413-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Sun L, Meng Y, Xie Y, Zhang H, Zhang Z, Wang X, Jiang B, Li W, Li Y, Yang Z. CTLA4 variants and haplotype contribute genetic susceptibility to myasthenia gravis in northern Chinese population. PLoS One 2014;9:e101986. [PMID: 25003519 DOI: 10.1371/journal.pone.0101986] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
16 Seok J, Ryu CH, Park SY, Lee CY, Lee YK, Hwangbo Y, Lee EK, Lee YJ, Kim TS, Kim SK, Jung YS, Ryu J. Factors Affecting Central Node Metastasis and Metastatic Lymph Node Ratio in Papillary Thyroid Cancer. Otolaryngol Head Neck Surg 2021;:194599821991465. [PMID: 33560176 DOI: 10.1177/0194599821991465] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Chen P, Fann CS, Chang C, Wu I, Chiu W, Lin C, Yang W, Chang T. Linkage of Graves? disease to the human leucocyte antigen region in the Chinese-Han population in Taiwan. Clin Endocrinol 2007;66:646-51. [DOI: 10.1111/j.1365-2265.2007.02787.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
18 Simmonds MJ, Gough SCL. Genetic insights into disease mechanisms of autoimmunity. British Medical Bulletin 2005;71:93-113. [DOI: 10.1093/bmb/ldh032] [Cited by in Crossref: 68] [Cited by in F6Publishing: 56] [Article Influence: 4.3] [Reference Citation Analysis]
19 Ban Y, Tozaki T, Taniyama M, Nakano Y, Yoneyama K, Ban Y, Hirano T. Association studies of the IL-23R gene in autoimmune thyroid disease in the Japanese population. Autoimmunity 2009;42:126-30. [PMID: 19021011 DOI: 10.1080/08916930802422265] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
20 Belchetz PE, Chu CE, Ajjan R. Chapter 11 Autoimmunity in Turner's, Down's, and Klinefelter's Syndromes. Endocrine Manifestations of Systemic Autoimmune Diseases. Elsevier; 2008. pp. 113-34. [DOI: 10.1016/s1571-5078(07)00211-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
21 Dittmar M, Kahaly GJ. Immunoregulatory and Susceptibility Genes in Thyroid and Polyglandular Autoimmunity. Thyroid 2005;15:239-50. [DOI: 10.1089/thy.2005.15.239] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
22 Skórka A, Bednarczuk T, Bar-Andziak E, Nauman J, Ploski R. Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correlation with age of onset. Clin Endocrinol (Oxf) 2005;62:679-82. [PMID: 15943829 DOI: 10.1111/j.1365-2265.2005.02279.x] [Cited by in Crossref: 97] [Cited by in F6Publishing: 88] [Article Influence: 6.1] [Reference Citation Analysis]
23 Jacobe H, Ahn C, Arnett FC, Reveille JD. Major histocompatibility complex class I and class II alleles may confer susceptibility to or protection against morphea: findings from the Morphea in Adults and Children cohort. Arthritis Rheumatol 2014;66:3170-7. [PMID: 25223600 DOI: 10.1002/art.38814] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
24 Zeitlin AA, Heward JM, Newby PR, Carr-smith JD, Franklyn JA, Gough SCL, Simmonds MJ. Analysis of HLA class II genes in Hashimoto's thyroiditis reveals differences compared to Graves’ disease. Genes Immun 2008;9:358-63. [DOI: 10.1038/gene.2008.26] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 4.7] [Reference Citation Analysis]
25 Winter W. Diabetes Autoimmunity. In: Lifshitz F, editor. Pediatric Endocrinology. CRC Press; 2006. pp. 83-99. [DOI: 10.3109/9781439808948-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
26 Mukai T, Hiromatsu Y, Ichimura M, Fukutani T, Kaku H, Miyake I, Shoji S, Koda Y, Bednarczuk T. Lack of Association of Interleukin-18 Gene Polymorphisms with Susceptibility of Japanese Populations to Graves' Disease or Graves' Ophthalmopathy. Thyroid 2006;16:243-8. [DOI: 10.1089/thy.2006.16.243] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
27 Ichimura M, Kaku H, Fukutani T, Koga H, Mukai T, Miyake I, Yamada K, Koda Y, Hiromatsu Y. Associations of Protein Tyrosine Phosphatase Nonreceptor 22 ( PTPN22 ) Gene Polymorphisms with Susceptibility to Graves' Disease in a Japanese Population. Thyroid 2008;18:625-30. [DOI: 10.1089/thy.2007.0353] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
28 Chen PL, Fann CS, Chu CC, Chang CC, Chang SW, Hsieh HY, Lin M, Yang WS, Chang TC. Comprehensive genotyping in two homogeneous Graves' disease samples reveals major and novel HLA association alleles. PLoS One 2011;6:e16635. [PMID: 21307958 DOI: 10.1371/journal.pone.0016635] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 4.3] [Reference Citation Analysis]
29 Jacobson EM, Huber AK, Akeno N, Sivak M, Li CW, Concepcion E, Ho K, Tomer Y. A CD40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of CD40 tissue-specific expression. Genes Immun. 2007;8:205-214. [PMID: 17344890 DOI: 10.1038/sj.gene.6364375] [Cited by in Crossref: 71] [Cited by in F6Publishing: 67] [Article Influence: 5.1] [Reference Citation Analysis]
30 Chen P, Fann CS, Chang C, Wu I, Chiu W, Lin C, Yang W, Chang T. Family-based association study of cytotoxic T-lymphocyte antigen-4 with susceptibility to Graves' disease in Han population of Taiwan. Genes Immun 2008;9:87-92. [DOI: 10.1038/sj.gene.6364445] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
31 Matana A, Popović M, Boutin T, Torlak V, Brdar D, Gunjača I, Kolčić I, Boraska Perica V, Punda A, Polašek O, Hayward C, Barbalić M, Zemunik T. Genome-wide meta-analysis identifies novel gender specific loci associated with thyroid antibodies level in Croatians. Genomics 2019;111:737-43. [DOI: 10.1016/j.ygeno.2018.04.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
32 Husebye ES, Anderson MS, Kämpe O. Autoimmune Polyendocrine Syndromes. N Engl J Med 2018;378:1132-41. [PMID: 29562162 DOI: 10.1056/NEJMra1713301] [Cited by in Crossref: 131] [Cited by in F6Publishing: 60] [Article Influence: 43.7] [Reference Citation Analysis]
33 Bowman C, Delrieu O. Immunogenetics of drug-induced skin blistering disorders. Part II: Synthesis. Pharmacogenomics 2009;10:779-816. [DOI: 10.2217/pgs.09.23] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Nakabayashi K, Tajima A, Yamamoto K, Takahashi A, Hata K, Takashima Y, Koyanagi M, Nakaoka H, Akamizu T, Ishikawa N, Kubota S, Maeda S, Tsunoda T, Kubo M, Kamatani N, Nakamura Y, Sasazuki T, Shirasawa S. Identification of independent risk loci for Graves’ disease within the MHC in the Japanese population. J Hum Genet 2011;56:772-8. [DOI: 10.1038/jhg.2011.99] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
35 Kisiel B, Bednarczuk T, Kostrzewa G, Kosińska J, Miśkiewicz P, Płazińska MT, Bar-Andziak E, Królicki L, Krajewski P, Płoski R. Polymorphism of the oestrogen receptor beta gene (ESR2) is associated with susceptibility to Graves' disease. Clin Endocrinol (Oxf) 2008;68:429-34. [PMID: 17941906 DOI: 10.1111/j.1365-2265.2007.03060.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
36 Chuang WY, Ströbel P, Gold R, Nix W, Schalke B, Kiefer R, Opitz A, Klinker E, Müller-Hermelink HK, Marx A. A CTLA4high genotype is associated with myasthenia gravis in thymoma patients. Ann Neurol 2005;58:644-8. [PMID: 16178018 DOI: 10.1002/ana.20577] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
37 Płoski R, Szymański K, Bednarczuk T. The genetic basis of graves' disease. Curr Genomics 2011;12:542-63. [PMID: 22654555 DOI: 10.2174/138920211798120772] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
38 Xu M, Bi Y, Cui B, Hong J, Wang W, Ning G. The new perspectives on genetic studies of type 2 diabetes and thyroid diseases. Curr Genomics 2013;14:33-48. [PMID: 23997649 DOI: 10.2174/138920213804999138] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
39 Rajaee A, Ebrahimi A, Ghiam AF, Kalantari T, Ghaderi A. Exon-1 polymorphism of ctla-4 gene is not associated with systemic sclerosis in Iranian patients. Rheumatol Int 2006;26:687-92. [PMID: 16189655 DOI: 10.1007/s00296-005-0047-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
40 Bednarczuk T, Gopinath B, Ploski R, Wall JR. Susceptibility genes in Graves' ophthalmopathy: searching for a needle in a haystack? Clin Endocrinol (Oxf) 2007;67:3-19. [PMID: 17521325 DOI: 10.1111/j.1365-2265.2007.02854.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
41 Walker MD, Zylberberg HM, Green PHR, Katz MS. Endocrine complications of celiac disease: a case report and review of the literature. Endocr Res 2019;44:27-45. [PMID: 30198791 DOI: 10.1080/07435800.2018.1509868] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
42 Jurecka-Lubieniecka B, Bednarczuk T, Ploski R, Krajewska J, Kula D, Kowalska M, Tukiendorf A, Kolosza Z, Jarzab B. Differences in Gene-Gene Interactions in Graves' Disease Patients Stratified by Age of Onset. PLoS One 2016;11:e0150307. [PMID: 26943356 DOI: 10.1371/journal.pone.0150307] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
43 Glanville KP, Coleman JRI, O'Reilly PF, Galloway J, Lewis CM. Investigating Pleiotropy Between Depression and Autoimmune Diseases Using the UK Biobank. Biol Psychiatry Glob Open Sci 2021;1:48-58. [PMID: 34278373 DOI: 10.1016/j.bpsgos.2021.03.002] [Reference Citation Analysis]
44 Medici M, Porcu E, Pistis G, Teumer A, Brown SJ, Jensen RA, Rawal R, Roef GL, Plantinga TS, Vermeulen SH, Lahti J, Simmonds MJ, Husemoen LL, Freathy RM, Shields BM, Pietzner D, Nagy R, Broer L, Chaker L, Korevaar TI, Plia MG, Sala C, Völker U, Richards JB, Sweep FC, Gieger C, Corre T, Kajantie E, Thuesen B, Taes YE, Visser WE, Hattersley AT, Kratzsch J, Hamilton A, Li W, Homuth G, Lobina M, Mariotti S, Soranzo N, Cocca M, Nauck M, Spielhagen C, Ross A, Arnold A, van de Bunt M, Liyanarachchi S, Heier M, Grabe HJ, Masciullo C, Galesloot TE, Lim EM, Reischl E, Leedman PJ, Lai S, Delitala A, Bremner AP, Philips DI, Beilby JP, Mulas A, Vocale M, Abecasis G, Forsen T, James A, Widen E, Hui J, Prokisch H, Rietzschel EE, Palotie A, Feddema P, Fletcher SJ, Schramm K, Rotter JI, Kluttig A, Radke D, Traglia M, Surdulescu GL, He H, Franklyn JA, Tiller D, Vaidya B, de Meyer T, Jørgensen T, Eriksson JG, O'Leary PC, Wichmann E, Hermus AR, Psaty BM, Ittermann T, Hofman A, Bosi E, Schlessinger D, Wallaschofski H, Pirastu N, Aulchenko YS, de la Chapelle A, Netea-Maier RT, Gough SC, Meyer Zu Schwabedissen H, Frayling TM, Kaufman JM, Linneberg A, Räikkönen K, Smit JW, Kiemeney LA, Rivadeneira F, Uitterlinden AG, Walsh JP, Meisinger C, den Heijer M, Visser TJ, Spector TD, Wilson SG, Völzke H, Cappola A, Toniolo D, Sanna S, Naitza S, Peeters RP. Identification of novel genetic Loci associated with thyroid peroxidase antibodies and clinical thyroid disease. PLoS Genet 2014;10:e1004123. [PMID: 24586183 DOI: 10.1371/journal.pgen.1004123] [Cited by in Crossref: 107] [Cited by in F6Publishing: 91] [Article Influence: 15.3] [Reference Citation Analysis]
45 Flynn JC, Mccormick DJ, Brusic V, Wan Q, Panos JC, Giraldo AA, David CS, Kong YM. Pathogenic human thyroglobulin peptides in HLA-DR3 transgenic mouse model of autoimmune thyroiditis. Cellular Immunology 2004;229:79-85. [DOI: 10.1016/j.cellimm.2004.07.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 1.9] [Reference Citation Analysis]
46 Fain PR, Babu SR, Bennett DC, Spritz RA. HLA class II haplotype DRB1*04-DQB1*0301 contributes to risk of familial generalized vitiligo and early disease onset. Pigment Cell Res 2006;19:51-7. [DOI: 10.1111/j.1600-0749.2005.00279.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
47 Ramos-Lopez E, Kurylowicz A, Bednarczuk T, Paunkovic J, Seidl C, Badenhoop K. Vitamin D receptor polymorphisms are associated with Graves' disease in German and Polish but not in Serbian patients. Thyroid 2005;15:1125-30. [PMID: 16279845 DOI: 10.1089/thy.2005.15.1125] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 2.5] [Reference Citation Analysis]
48 Kanga U, Tandon N, Marwaha RK, Khanna R, Bhattacharya B, Singh S, Kumar N, Mehra NK. Immunogenetic association and thyroid autoantibodies in juvenile autoimmune thyroiditis in North India. Clin Endocrinol 2006;64:573-9. [DOI: 10.1111/j.1365-2265.2006.02511.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
49 Hayashi M, Kouki T, Takasu N, Sunagawa S, Komiya I. Association of an A/C single nucleotide polymorphism in programmed cell death-ligand 1 gene with Graves' disease in Japanese patients. Eur J Endocrinol 2008;158:817-22. [PMID: 18322304 DOI: 10.1530/EJE-07-0649] [Cited by in Crossref: 32] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]